Literature DB >> 23104264

The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats.

Pietro Cottone1, Attilio Iemolo, Aditi R Narayan, Jina Kwak, Duncan Momaney, Valentina Sabino.   

Abstract

RATIONALE: Impulsive behavior is categorically differentiated between impulsive action, the inability to withhold from acting out a response, and impulsive choice, the greater preference for an immediate and smaller reward over a delayed but more advantageous reward. While the effects of N-methyl-D-aspartic acid (NMDA) receptor antagonists on impulsive action have been extensively characterized, there are very few and conflicting reports on the effects of this class of drugs on impulsive choice.
OBJECTIVES: Using a modified adjusting delay task, we investigated the effects of uncompetitive and competitive blockade of NMDA receptors on impulsive choice.
METHODS: Male Wistar rats were trained in a modified adjusting delay task, which involved repeated choice between a low reinforcing solution delivered immediately and a highly reinforcing solution delivered after a variable delay. Rats were then administered either the NMDA receptor uncompetitive antagonists ketamine or memantine, or the competitive antagonists D-AP-5 or CGS 19755.
RESULTS: Ketamine treatment dose-dependently increased impulsive choice, and this effect was selective for low-impulsive but not high-impulsive rats. Similarly, memantine treatment dose-dependently increased impulsive choice with a preferential effect for low-impulsive rats. While D-AP-5 treatment did not affect impulsive choice, CGS 19755 increased impulsivity, however, at the same doses at which it caused a marked response inhibition.
CONCLUSIONS: NMDA receptor uncompetitive, but not competitive, antagonists significantly increased impulsive choice, preferentially in low-impulsive rats. These findings demonstrate that the effects of NMDA receptor blockade on impulsive choice are not generalizable and depend on the specific mechanism of action of the antagonist used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104264      PMCID: PMC3572289          DOI: 10.1007/s00213-012-2898-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  66 in total

Review 1.  Varieties of impulsivity.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

2.  Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

Authors:  A J Grottick; G A Higgins
Journal:  Behav Brain Res       Date:  2000-12-20       Impact factor: 3.332

3.  To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity.

Authors:  Marc N Potenza
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

4.  N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats.

Authors:  L S Leung; B Shen
Journal:  Hippocampus       Date:  1999       Impact factor: 3.899

Review 5.  Psychiatric aspects of impulsivity.

Authors:  F G Moeller; E S Barratt; D M Dougherty; J M Schmitz; A C Swann
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

Review 6.  On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder.

Authors:  M L Carlsson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-01       Impact factor: 5.067

7.  Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate.

Authors:  F Paoli; G Spignoli; G Pepeu
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.

Authors:  D A Bennett; P S Bernard; C L Amrick; D E Wilson; J M Liebman; A J Hutchison
Journal:  J Pharmacol Exp Ther       Date:  1989-08       Impact factor: 4.030

9.  A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats.

Authors:  W Koek; J H Woods; P Ornstein
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism.

Authors:  Guy A Higgins; Michel Enderlin; Marie Haman; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2003-08-07       Impact factor: 4.530

View more
  27 in total

1.  Effects of Group I metabotropic glutamate receptor antagonists on sensitivity to reinforcer magnitude and delayed reinforcement in a delay-discounting task in rats: Contribution of delay presentation order.

Authors:  Justin R Yates; Katherine K Rogers; Benjamin T Gunkel; Nicholas A Prior; Mallory N Hughes; Sara M Sharpe; Hunter L Campbell; Anthony B Johnson; Margaret G Keller; Kerry A Breitenstein; Hansen N Shults
Journal:  Behav Brain Res       Date:  2017-01-12       Impact factor: 3.332

2.  N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers.

Authors:  Suchitra Krishnan-Sarin; Stephanie S O'Malley; Nicholas Franco; Dana A Cavallo; Meghan Morean; Julia Shi; Brian Pittman; John H Krystal
Journal:  Alcohol Clin Exp Res       Date:  2015-02-09       Impact factor: 3.455

3.  Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice.

Authors:  Andrew Nathanael Shen; M Christopher Newland
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

4.  Profile of cortical N-methyl-D-aspartate receptor subunit expression associates with inherent motor impulsivity in rats.

Authors:  Brionna D Davis-Reyes; Veronica M Campbell; Michelle A Land; Holly L Chapman; Susan J Stafford; Noelle C Anastasio
Journal:  Biochem Pharmacol       Date:  2019-07-08       Impact factor: 5.858

5.  Effects of NMDA receptor antagonists on probability discounting depend on the order of probability presentation.

Authors:  Justin R Yates; Kerry A Breitenstein; Benjamin T Gunkel; Mallory N Hughes; Anthony B Johnson; Katherine K Rogers; Sara M Shape
Journal:  Pharmacol Biochem Behav       Date:  2016-09-15       Impact factor: 3.533

6.  Effects of intra-accumbal administration of dopamine and ionotropic glutamate receptor drugs on delay discounting performance in rats.

Authors:  Justin R Yates; Michael T Bardo
Journal:  Behav Neurosci       Date:  2017-10       Impact factor: 1.912

Review 7.  Dissecting drug effects in preclinical models of impulsive choice: emphasis on glutamatergic compounds.

Authors:  Justin R Yates
Journal:  Psychopharmacology (Berl)       Date:  2018-01-06       Impact factor: 4.530

Review 8.  Do specific NMDA receptor subunits act as gateways for addictive behaviors?

Authors:  F W Hopf
Journal:  Genes Brain Behav       Date:  2016-11-18       Impact factor: 3.449

9.  Effects of GluN2B-selective antagonists on delay and probability discounting in male rats: Modulation by delay/probability presentation order.

Authors:  Justin R Yates; Nicholas A Prior; Marissa R Chitwood; Haley A Day; Jonah R Heidel; Sarah E Hopkins; Brittany T Muncie; Tatiana A Paradella-Bradley; Alexandra P Sestito; Ashley N Vecchiola; Emily E Wells
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

Review 10.  Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.

Authors:  Faryal Mallick; Cheryl B McCullumsmith
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.